+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infectious Diseases Drugs Market Research Reports

From
Dengue Fever - Pipeline Insight, 2026 - Product Thumbnail Image

Dengue Fever - Pipeline Insight, 2026

  • Drug Pipelines
  • May 2026
  • 60 Pages
  • Global
From
Pneumococcal Infections - Pipeline Insight, 2026 - Product Thumbnail Image

Pneumococcal Infections - Pipeline Insight, 2026

  • Drug Pipelines
  • May 2026
  • 80 Pages
  • Global
From
COVID-19 - Pipeline Insight, 2026 - Product Thumbnail Image

COVID-19 - Pipeline Insight, 2026

  • Drug Pipelines
  • May 2026
  • 280 Pages
  • Global
From
BK Virus (BKV) Infection - Pipeline Insight, 2026 - Product Thumbnail Image

BK Virus (BKV) Infection - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 60 Pages
  • Global
From
Candidiasis - Pipeline Insight, 2026 - Product Thumbnail Image

Candidiasis - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2026 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 180 Pages
  • Global
From
Clostridium Difficile Infections - Pipeline Insight, 2026 - Product Thumbnail Image

Clostridium Difficile Infections - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 80 Pages
  • Global
From
From
HSV 1 Keratitis - Pipeline Insight, 2026 - Product Thumbnail Image

HSV 1 Keratitis - Pipeline Insight, 2026

  • Drug Pipelines
  • April 2026
  • 60 Pages
  • Global
From
MNKD-101 Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

MNKD-101 Sales Forecast and Market Size Analysis - 2034

  • Report
  • March 2026
  • 30 Pages
  • Global
From
Ebola Virus - Competitive Landscape, 2026 - Product Thumbnail Image

Ebola Virus - Competitive Landscape, 2026

  • Report
  • January 2026
  • 80 Pages
  • Global
From
HSV-1 Keratitis - Competitive Landscape, 2026 - Product Thumbnail Image

HSV-1 Keratitis - Competitive Landscape, 2026

  • Report
  • January 2026
  • 60 Pages
  • Global
From
From
From
From
From
From
From
Hepatitis D Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Hepatitis D Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
Loading Indicator

The Infectious Diseases Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of illnesses, from common colds to more serious conditions such as HIV/AIDS, malaria, and tuberculosis. The market is highly competitive, with many companies vying for a share of the market. Infectious Diseases Drugs are typically developed through a combination of research and development, clinical trials, and regulatory approval. Companies in the market must also ensure that their products are safe and effective for use in humans. Some of the major players in the Infectious Diseases Drugs market include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Johnson & Johnson. These companies are involved in the development and production of a wide range of drugs used to treat infectious diseases. Show Less Read more